Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-24-105345
Filing Date
2024-09-11
Accepted
2024-09-11 08:40:02
Documents
5
Group Members
KAYAK MERGECOTUHURA BIOSCIENCES INC.

Document Format Files

Seq Description Document Type Size
1 425 ktra_425_20240911_sh_com.htm 425 65062
2 EX-99.1 ktra-ex99_1.htm EX-99.1 42294
3 EX-99.2 ktra-ex99_2.htm EX-99.2 23773
4 GRAPHIC img40499469_0.jpg GRAPHIC 115627
5 GRAPHIC img41422990_0.jpg GRAPHIC 24913
  Complete submission text file 0000950170-24-105345.txt   326986
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filed by) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-37823 | Film No.: 241291482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)